STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention
| Status: | Recruiting |
|---|---|
| Conditions: | Liver Cancer, Cancer, Hepatitis, Hepatitis |
| Therapuetic Areas: | Immunology / Infectious Diseases, Oncology |
| Healthy: | No |
| Age Range: | 53 - 74 |
| Updated: | 3/2/2019 |
| Start Date: | September 10, 2018 |
| End Date: | June 2020 |
| Contact: | Patrice Perryman, MPH |
| Email: | patrice.perryman@utsouthwestern.edu |
| Phone: | 214-648-3803 |
STOP-HCC Evidence-Based Hepatocellular Cancer Prevention Through Treatment of Hepatitis C Virus Infection
Aim 1: The investigators will conduct a randomized controlled trial comparing two strategies
to promote HCV screening, follow-up testing, and treatment among baby-boomers (i.e. persons
born between 1945-1965): inreach with electronic medical record alerts and provider education
vs. combination of inreach and provider education plus mailed outreach and patient
navigation.
Aim 2: The investigators will evaluate patient navigation strategies to promote follow-up
testing and treatment evaluation among non-baby boomer Parkland patients (i.e. born before
1945 or after 1965) who are either: a) HCV antibody positive but have not completed follow-up
viral load testing or b) HCV viral load positive and who have not completed in-clinic
treatment evaluation.
to promote HCV screening, follow-up testing, and treatment among baby-boomers (i.e. persons
born between 1945-1965): inreach with electronic medical record alerts and provider education
vs. combination of inreach and provider education plus mailed outreach and patient
navigation.
Aim 2: The investigators will evaluate patient navigation strategies to promote follow-up
testing and treatment evaluation among non-baby boomer Parkland patients (i.e. born before
1945 or after 1965) who are either: a) HCV antibody positive but have not completed follow-up
viral load testing or b) HCV viral load positive and who have not completed in-clinic
treatment evaluation.
Inclusion Criteria:
- born between 1945 and 1965
- ≥ 1 outpatient visit during 12 months prior to randomization at Parkland
- no prior HCV screening (prior HCV antibody, viral load, or genotype).
- any active medical coverage
- speaks Spanish or English
Exclusion Criteria:
- a life expectancy less than one year including end stage CHF, end stage COPD,
metastatic cancer, and those who received a palliative care or hospice referral in the
past year
- history of HCC.
- non-English or Spanish speakers
- no address or phone number on file
We found this trial at
1
site
Click here to add this to my saved trials
